When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IKT - Inhibikase Therapeutics prices stock offering at $3
Inhibikase Therapeutics Inc.
Inhibikase Therapeutics (IKT) has priced its public offering of 15M common shares at $3.00/share for total gross proceeds of ~$45M.Underwriters' over-allotment is an additional 2.25M shares. Net proceeds will be used for development of product candidates, for R&D activities, and other general corporate purposes.Closing date is June 18.Shares down 23% after-hours. Yesterday's close was $4.04.